We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$207B
AUM Growth
+$20.6B
Cap. Flow
+$7.57B
Cap. Flow %
3.65%
Top 10 Hldgs %
26.62%
Holding
9,816
New
1,347
Increased
3,275
Reduced
3,438
Closed
1,488

Sector Composition

Rank Sector Weight
1 Consumer Staples 2.31%
2 Technology 1.26%
3 Financials 1.12%
4 Healthcare 1.04%
5 Consumer Discretionary 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFC
9151
DELISTED
Premier Financial Corp. Common Stock
PFC
-28,800
Closed -$559K
ROIC
9152
CALL
DELISTED
Retail Opportunity Investments Corp.
ROIC
-9,400
Closed -$204K
RVNC
9153
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
-14,800
Closed -$201K
B
9154
DELISTED
Barnes Group Inc.
B
-16,005
Closed -$622K
CNSL
9155
PUT
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
-22,700
Closed -$618K
SAVE
9156
DELISTED
Spirit Airlines, Inc.
SAVE
-37,865
Closed -$1.57M
PRMW
9157
DELISTED
Primo Water Corporation
PRMW
-58,171
Closed -$892K
PRMW
9158
PUT
DELISTED
Primo Water Corporation
PRMW
-16,600
Closed -$232K
SRCL
9159
DELISTED
Stericycle Inc
SRCL
-13,010
Closed -$1.18M
ORAN
9160
DELISTED
Orange
ORAN
-17,200
Closed -$265K
SEEL
9161
CALL
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
-$26K
EGIO
9162
CALL
DELISTED
Edgio, Inc. Common Stock
EGIO
-1,015
Closed -$60K
ASXC
9163
DELISTED
Asensus Surgical, Inc.
ASXC
-13,615
Closed -$249K
MMAT
9164
DELISTED
Meta Materials Inc. Common Stock
MMAT
-373
Closed -$41K
WRK
9165
DELISTED
WestRock Company
WRK
-70,584
Closed -$3.15M
WIRE
9166
DELISTED
Encore Wire Corp
WIRE
-23,628
Closed -$904K
BIOL
9167
DELISTED
Biolase, Inc.
BIOL
-1
Closed -$16K
STAF
9168
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
-5
Closed -$23K
TAST
9169
CALL
DELISTED
Carrols Restaurant Group, Inc.
TAST
-12,900
Closed -$154K
VIA
9170
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
-4,000
Closed -$331K
PXD
9171
DELISTED
Pioneer Natural Resource Co.
PXD
-138,632
Closed -$23.6M
NGE
9172
DELISTED
Global X MSCI Nigeria ETF
NGE
-7,069
Closed -$152K
BKCC
9173
CALL
DELISTED
BlackRock Capital Investment Corporation
BKCC
-48,100
Closed -$374K
BFX
9174
DELISTED
BowFlex Inc.
BFX
-10,482
Closed -$223K
BFX
9175
PUT
DELISTED
BowFlex Inc.
BFX
-10,900
Closed -$194K

Similar funds

Jeff Yass's Q3 2016 Portfolio in Review

As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.

By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $762M trimmed.

  • Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
  • Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
  • Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
  • Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
  • Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
  • Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
  • Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.

Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.